Gemini to Participate in Citi’s 14th Annual FinTech Conference

(NASDAQ:GEMI), NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) today announced that Marshall Beard, Chief Operating Officer, and Dan Chen, Chief Financial Officer, will attend Citi's 14th Annual FinTech Conference on November 18, 2025. Management will be available for one-on-one and small group investor meetings. Channels for Disclosure […]

Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

(NASDAQ:CJMB), Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding

Materialise NV Announces Results of 2025 Extraordinary Shareholders’ Meeting

(NASDAQ:MTLS), Leuven, Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) — Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing solutions, today announced the results of the votes cast at its Extraordinary Shareholders' Meeting, where all the proposed resolutions were approved. For additional information, please visit: https://investors.materialise.com/ About Materialise NV

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

(NasdaqGM:VRCA), – Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH(R) revenue and $10.7 million of license and collaboration revenue – – Reports positive feedback from the FDA and alignment regarding the study design of a Phase 3 program for VP-315 in basal cell carcinoma; Company presented new data on

First Merchants Corporation Announces Cash Dividend

(NASDAQ:FRME), MUNCIE, Ind., Nov. 14, 2025 (GLOBE NEWSWIRE) — First Merchants Corporation declared a cash dividend on November 14, 2025 of $0.36 per common share. The dividend is payable on December 19, 2025, to common shareholders of record as of December 5, 2025. About First Merchants Corporation: First Merchants Corporation is a financial holding company

Capital Bancorp Appoints Jacob Dalaya as Chief Financial Officer

(NASDAQ:CBNK), ROCKVILLE, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) — Capital Bancorp, Inc. (NASDAQ: CBNK) today announced the appointment of Jacob Dalaya as Executive Vice President and Chief Financial Officer of Capital Bancorp and Capital Bank, National Association, effective immediately. Prior to his appointment, Mr. Dalaya served as Chief Strategy Officer, where he played a key

Dragonfly Energy Reports Third Quarter 2025 Results

(NASDAQ:DFLI),(NASDAQ:DFLIW), Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM GrowthGross Margin Expanded 710 Basis Points Year-over-YearRecent Public Offerings and Debt Restructuring Significantly Improve Financial PositionGuides to Fourth Quarter Net Sales of Approximately $13.0 Million Third Quarter 2025 Financial Highlights (All comparisons made are against the prior-year period) Net sales were

Epsilon Announces the Closing of the Acquisitions of the Peak Companies With Assets in the Powder River Basin

(NasdaqGM:EPSN), HOUSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company“) (NASDAQ: EPSN) today reported the consummation of the previously announced acquisitions of Peak Exploration and Production LLC and Peak BLM Lease LLC (together, the “Peak Companies“) (the “Closing“). The Closing followed a special meeting of the Company's shareholders held on

Biogen Completes Acquisition of Alcyone Therapeutics

(NASDAQ:BIIB),(NASDAQ:IONS), CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx(TM) drug delivery system. ThecaFlex DRx(TM) is an investigational implantable device designed to provide an alternative to repeat lumbar

The Marketing Alliance Announces Financial Results for Fiscal Second Quarter Ended September 30, 2025

(PinkSheets:MAAL),(Pinksheets:MAAL), ST. LOUIS, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), announced its financial results today for its fiscal 2026 second quarter ended September 30, 2025. Q2 2026 Financial Key Items (all comparisons to the prior year quarter) Revenues from operations were $4,668,836 compared to $4,983,950, a

Scroll to Top